Navigation Links
Med Discovery and Laborium Biopharma Sign a Bioprocess Development Partnership Agreement
Date:11/19/2008

eadquartered in Geneva, Switzerland focusing on treatments for uro-genital cancers. The company is dedicated to the discovery and the development of highly specific protein drugs based on the optimization of natural proteins involved in the regulation of biological pathways. The company is leveraging a strong in-house expertise combined with an international network in clinical urology.

Laborium Biopharma is a private corporation based in the Biotechnology Research Institute of the National Research Council Canada in Montreal, Quebec. This new company is dedicated to the development and optimization of bio-production processes and the cGMP manufacturing of clinical batches of high-potency products.

###

Read the full story at http://www.prweb.com/releases/2008/11/prweb1641134.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

1

GOOD

Page: 1 2

Related biology technology :

1. Telik Announces New TRAP Drug Discovery Agreement
2. MaxCyte Hosts Live Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery
3. TIBCO Speeds Drug Discovery for Chemists
4. Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts
5. deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer
6. Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
7. The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
8. Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration
9. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11
10. Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)
11. Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Med Discovery and Laborium Biopharma Sign a Bioprocess Development Partnership Agreement
Med Discovery and Laborium Biopharma Sign a Bioprocess Development Partnership Agreement
(Date:12/15/2009)... Epeius Biotechnologies Corporation, an emerging leader ... international validation of the cutting-edge science behind its ... around the world rediscovered the Cyclin G1 ... cancer pathogenesis and disease progression, and thus a ... the NIH National Cancer Institute investigating the role ...
(Date:12/15/2009)... one of three Department of Energy (DOE) bio-energy research ... protect its valuable intellectual property. , ... ... 2009 -- Surety, LLC , the leading provider ... that the Joint BioEnergy Institute (JBEI), one of three ...
(Date:12/15/2009)... WALTHAM, Mass., Dec. 15 Repligen Corporation ... Company has received $731,000 in research funding to ... Friedreich,s ataxia from the Muscular Dystrophy Association (MDA). ... preclinical GLP toxicology testing and GMP manufacture of ... Support from the MDA not only provides important ...
(Date:12/15/2009)... /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... ), a,leading fully integrated pharmaceutical company developing and ... ("PRC"), today,announced that the Company has 30 medicines ... the National Basic Medical Insurance, Industrial Injury Insurance,and ... The 30 medicines treat a variety of ...
Breaking Biology Technology:Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3
... Calif., March 10 Beckman Coulter,Inc. (NYSE: ... of,products that simplify, automate, and innovate complex biomedical ... Vice President of,Strategy and Business Development, will present ... Thursday, March 13, 2008, at 4:00 a.m.,(ET)., ...
... 10 /PRNewswire-FirstCall/ - Oncothyreon Inc.,(Nasdaq: ONTY ) (TSX: ... and quarter ended December 31, 2007. All results are ... loss for the year ended December 31, 2007, was ... with $36.4 million, or $2.38,per basic and diluted share ...
... News and, add to it in-Depth Analysis and Commentary That ... ... March 10 Elsevier, the world,s,leading publisher of science, technical ... Inc., a healthcare,business intelligence company that provides analysis and commentary ...
Other Biology Technology:Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference 2Oncothyreon reports full year and fourth quarter 2007 financial results 2Oncothyreon reports full year and fourth quarter 2007 financial results 3Oncothyreon reports full year and fourth quarter 2007 financial results 4Oncothyreon reports full year and fourth quarter 2007 financial results 5Oncothyreon reports full year and fourth quarter 2007 financial results 6Oncothyreon reports full year and fourth quarter 2007 financial results 7Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company 2Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company 3
(Date:12/14/2009)... -- Researchers at Rice University and Baylor College of ... be tracked in real time with MRI as it ... fluorescent dye and kills them with heat. The all-in-one ... growing field called "theranostics" that develops technologies physicians can ... procedure. , The research is available online in the ...
(Date:12/14/2009)... Infectious diseases can be transmitted by sneezing, touching, or ... the face, a habit that may have driven the ... parasite. , Jacqueline Upcroft, a member of f1000 Biology, ... colleagues published in PLoS One. This led them to ... the diseased jaw bones seen in many tyrannosaurid fossils. ...
(Date:12/14/2009)... HAMILTON, ON, December 10, 2009If you are spending the ... and wondering whether you would be better off with ... fish. , A research team from McMaster University ... that among cichlids, a species that lives in groups, ... , The results appear in the current issue of ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2North Highland Opens First Asia Office in Shanghai 52919 1North Highland Opens First Asia Office in Shanghai 52919 2Resvera Health Rx Launches All Natural Resveratrol Based Supplement with Anti Aging and Disease Fighting Properties 52917 1Resvera Health Rx Launches All Natural Resveratrol Based Supplement with Anti Aging and Disease Fighting Properties 52917 2Resvera Health Rx Launches All Natural Resveratrol Based Supplement with Anti Aging and Disease Fighting Properties 52917 3RadMD First to Offer CME Certified Education and Training For Medical Imaging in Clinical Trials 13230 1RadMD First to Offer CME Certified Education and Training For Medical Imaging in Clinical Trials 13230 2
... expressions of emotion are hardwired into our genes, according ... of Personality and Social Psychology . The research suggests ... a product of cultural learning. The study is the ... blind individuals use the same facial expressions, producing the ...
... 9 First Coast Service Options (FCSO) has ... Medicare reimbursement solutions, to support a new Medicare ... & Medicaid Services (CMS).Under this new contract, FCSO ... between health care providers and organizations offering Medicare ...
... at the University of Warwick has discovered the trigger that ... stage of embryo development. Their discovery could also provide new ... and are bound together at key parts of analogous cell ... binding togetgher of too many of too few of a ...
Other Biology News:Facial expressions of emotion are innate, not learned, says new study 2FCSO Selects Burgess as Exclusive Pricing Solution for New Medicare Contract 2How chromosomes meet in the dark -- Switch that turns on X chromosome matchmaking 2How chromosomes meet in the dark -- Switch that turns on X chromosome matchmaking 3
... Series Systems provide fast and reliable ... proteomics and drug development laboratories. Staccato ... customer specifications, providing solutions that are ... Staccato Custom Systems are controlled with ...
... Use in any standard fixed-angle ... 16,000 g.,Spin- centrifuge tube filters ... within a centrifuge tube. They filter ... removal, HPLC sample preparation, removal of ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Material: polystyrene ...
... optically clear polystyrene formulation , High antibody-binding ... , Plates are certified for performance ... , Eight-well strips fit snugly in ... in use even if turned upside down ...
Biology Products: